GlassScriptPhysician profile
Sumant Lamba
NPI 1306804687
$25,233.10
in general payments reported to CMS, 2019-2025
57 companies · $2,250 in 2025
The $2,250 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,435 · 2021: $2,112 · 2022: $2,437 · 2023: $3,977 · 2024: $1,849 · 2025: $2,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,056 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,055.59 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,556.66 | 2019-2025 | Xact, Amplatzer Amulet, Diamondback Coronary |
| Abiomed | $4,547.07 | 2019-2025 | Impella |
| Cvrx, INC. | $1,599.68 | 2021-2025 | Barostim Neo System |
| Cardiovascular Systems INC. | $1,032.52 | 2019-2023 | Diamondback Coronary |
| Medtronic, INC. | $954.78 | 2021-2023 | Onyx Frontier, Abre, Linq II |
| Actelion Pharmaceuticals US, INC. | $938.03 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Amgen INC. | $635.17 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $563.89 | 2020-2023 | Watchman Flx, Ekosonic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $439.56 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $428.37 | 2019-2025 | Lokelma, Farxiga, Wainua |
| Medtronic Vascular, INC. | $395.27 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $384.18 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $345.80 | 2021-2025 | Verquvo, Winrevair |
| Janssen Pharmaceuticals, INC | $282.54 | 2020-2024 | Xarelto |
| Pfizer INC. | $270.23 | 2019-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $253.04 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Circulation INC | $195.22 | 2020-2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Acist Medical Systems, INC. | $189.06 | 2025 | |
| Inspire Medical Systems, INC. | $151.99 | 2021-2024 | Inspire |
| Siemens Medical Solutions USA, INC. | $149.18 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.09 | 2021-2024 | |
| Shockwave Medical, INC | $143.06 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $138.00 | 2022-2023 | Optimizer |
| Sanofi-Aventis U.S. LLC | $126.85 | 2021-2023 | |
| Avantec Vascular Corporation | $116.67 | 2023 | |
| Edwards Lifesciences Corporation | $99.29 | 2021 | |
| United Therapeutics Corporation | $94.70 | 2021-2025 | Tyvaso |
| Philips North America LLC | $89.73 | 2019-2024 | (Ck4) Mcot |
| Penumbra, INC. | $88.49 | 2019-2024 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $88.26 | 2024-2025 | Camzyos, Eliquis |
| Innovation Technologies INC | $74.17 | 2024-2025 | Irrisept |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.29 | 2023-2025 | Lifevest |
| Daiichi Sankyo INC. | $55.11 | 2019-2024 | Injectafer |
| Livanova USA, INC. | $41.41 | 2022 | |
| Chiesi USA, INC. | $41.05 | 2019 | |
| Biotronik INC. | $40.82 | 2020 | |
| Alnylam Pharmaceuticals INC. | $38.24 | 2021-2025 | Amvuttra |
| Kestra Medical Technology Services, INC. | $37.40 | 2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $37.10 | 2023-2024 | Inpefa |
| Glaxosmithkline, LLC. | $36.50 | 2022-2023 | Arexvy, Trelegy Ellipta |
| Esperion Therapeutics, INC. | $36.39 | 2020-2023 | Nexletol |
| Novo Nordisk INC | $35.12 | 2021 | |
| Irhythm Technologies, INC. | $33.64 | 2022 | |
| Baxter Healthcare | $30.38 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $29.66 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $25.38 | 2024 | Arcalyst |
| Atricure, INC. | $24.70 | 2025 | Synergy Ablation System |
| Bardy Diagnostics, INC. | $24.00 | 2022 | |
| Gilead Sciences, INC. | $18.53 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.49 | 2020 | |
| Astellas Pharma US INC | $17.03 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.40 | 2024 | Evkeeza |
| Scpharmaceuticals INC. | $14.91 | 2024 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumant Lamba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.